Aug 5, 2026 10:26AM
Aug 5, 2026 10:25AM
Aug 4, 2026 09:05AM
Aug 3, 2026 02:37PM
Jul 30, 2026 08:30AM
Jul 30, 2026 08:30AM
Jul 23, 2026 08:31AM J&J myeloma drug combo cuts disease progression risk by 89% in trial
Jul 23, 2026 08:30AM
Jul 22, 2026 07:01AM
Jul 22, 2026 07:00AM
Jul 15, 2026 06:20AM
Jul 8, 2026 07:45AM
Jul 8, 2026 07:45AM
Jun 30, 2026 09:00AM Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Jun 26, 2026 12:35PM
Jun 26, 2026 12:35PM
Jun 14, 2026 02:01PM
Jun 13, 2026 06:33AM
Jun 11, 2026 07:45AM
Jun 11, 2026 07:45AM
Jun 11, 2026 07:43AM Johnson & Johnson reports positive results for rare blood disorder treatment
Jun 11, 2026 02:03AM
Jun 11, 2026 02:03AM
Jun 3, 2026 03:14AM
Jun 3, 2026 12:04AM
Jun 3, 2026 12:04AM
Jun 3, 2026 12:03AM
May 31, 2026 08:29AM RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
May 31, 2026 08:28AM
May 31, 2026 08:27AM
May 29, 2026 02:00PM
May 29, 2026 02:00PM
May 29, 2026 08:41AM
May 29, 2026 08:18AM
May 28, 2026 07:10PM FDA approves expanded TREMFYA label for joint damage prevention
May 28, 2026 07:10PM
May 15, 2026 02:58PM
May 13, 2026 08:30AM
May 11, 2026 08:01AM
May 11, 2026 08:00AM
May 5, 2026 08:05AM
May 5, 2026 08:05AM Johnson & Johnson reports positive phase 2b results for experimental IBD therapy
May 5, 2026 08:05AM
May 5, 2026 08:05AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 4, 2026 08:03AM
May 4, 2026 08:00AM
Apr 27, 2026 08:03AM FDA grants priority review to J&J's IMAAVY for rare blood disorder
Apr 27, 2026 08:03AM

327,488 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All